Literature DB >> 1698171

Histological features and clinical course of large regenerative nodules: evaluation of their precancerous potentiality.

F Kondo1, M Ebara, N Sugiura, K Wada, K Kita, N Hirooka, Y Nagato, Y Kondo, M Ohto, K Okuda.   

Abstract

Seventeen patients with cirrhosis and histologically defined, ultrasonically detected, large regenerative nodules of the liver were followed without treatment for more than 1 yr (range = 13 to 51 mo). During the follow-up period, none of the nodules were demonstrated sonographically to have enlarged. Computed tomography and/or hepatic angiography were also performed in 14 patients, but there was no evidence of malignant transformation in these lesions. None of the 17 patients showed acute elevation of serum alpha-fetoprotein levels. Furthermore, four nodules became undetectable by these imaging procedures. Follow-up biopsy performed in seven patients revealed no significant histological changes from the first biopsy sample. However, HCCs developed apart from these large regenerative nodules in four patients. These HCCs suddenly appeared and did not seem to have been derived from preexisting large regenerative nodules. From these observations, it was not possible to regard a large regenerative nodule having no cytological atypia as a high-potential premalignant lesion. Their precancerous potentiality needs to be compared with that of ordinary pseudolobules.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698171     DOI: 10.1002/hep.1840120324

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

1.  Classification tool for the systematic histological assessment of hepatocellular carcinoma, macroregenerative nodules, and dysplastic nodules in cirrhotic liver.

Authors:  A Quaglia; M A Jutand; A Dhillon; A Godfrey; R Togni; P Bioulac-Sage; C Balabaud; M Winnock; A P Dhillon
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

2.  Comparison of the proliferative capacity of adenomatous hyperplasia and well differentiated hepatocellular carcinoma.

Authors:  A Yamashita
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

3.  Management of adenomatous hyperplastic nodules in the cirrhotic liver: US follow-up or percutaneous alcohol ablation?

Authors:  R Lencioni; C Bartolozzi; D Caramella; G Di Coscio
Journal:  Abdom Imaging       Date:  1993

4.  Histological features of early hepatocellular carcinomas and their developmental process: for daily practical clinical application : Hepatocellular carcinoma.

Authors:  Fukuo Kondo
Journal:  Hepatol Int       Date:  2008-11-14       Impact factor: 6.047

5.  Enzymatic cytochemistry, DNA ploidy and AgNOR quantitation in hepatocellular nodules of uncertain malignant potential in liver cirrhosis.

Authors:  L Bolondi; L Gramantieri; P Chieco; C Melchiorri; D Treré; B Stecca; M Derenzini; L Barbara
Journal:  Dig Dis Sci       Date:  1996-04       Impact factor: 3.199

6.  Genomic heterogeneity in synchronous hepatocellular carcinomas.

Authors:  Y Sirivatanauksorn; V Sirivatanauksorn; S Bhattacharya; B R Davidson; A P Dhillon; A K Kakkar; R C Williamson; N R Lemoine
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

7.  Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study.

Authors:  E Caturelli; L Solmi; M Anti; S Fusilli; P Roselli; A Andriulli; F Fornari; C Del Vecchio Blanco; I de Sio
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

8.  Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study.

Authors:  Tsunenobu Sato; Fukuo Kondo; Masaaki Ebara; Nobuyuki Sugiura; Shinichiro Okabe; Masahiko Sunaga; Masaharu Yoshikawa; Eiichiro Suzuki; Sadayuki Ogasawara; Yusuke Shinozaki; Yoshihiko Ooka; Tetsuhiro Chiba; Fumihiko Kanai; Takashi Kishimoto; Yukio Nakatani; Toshio Fukusato; Osamu Yokosuka
Journal:  Hepatol Int       Date:  2015-03-03       Impact factor: 6.047

9.  No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.

Authors:  Masato Nakamura; Tatsuo Kanda; Shingo Nakamoto; Tatsuo Miyamura; Xia Jiang; Shuang Wu; Osamu Yokosuka
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

10.  Liver disease severity predicts carcinogenesis of dysplastic liver nodules in cirrhosis.

Authors:  Kathryn Gazelakis; Ammar Majeed; William Kemp; Bruno Di Muzio; Jan Gerstenmaier; Wa Cheung; Stuart K Roberts
Journal:  Sci Rep       Date:  2021-10-25       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.